Metropolitan Life Insurance Company (MetLife)’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,040
| Closed | -$15.5K | – | 224 |
|
|
2024
Q1 | $15.5K | Sell |
3,040
-1,303
| -30% | -$6.63K | ﹤0.01% | 1971 |
|
|
2023
Q4 | $40.4K | Hold |
4,343
| – | – | ﹤0.01% | 1559 |
|
|
2023
Q3 | $28.4K | Buy |
4,343
+786
| +22% | +$5.15K | ﹤0.01% | 1710 |
|
|
2023
Q2 | $28.9K | Hold |
3,557
| – | – | ﹤0.01% | 1730 |
|
|
2023
Q1 | $30.5K | Sell |
3,557
-598
| -14% | -$5.13K | ﹤0.01% | 1676 |
|
|
2022
Q4 | $38.5K | Hold |
4,155
| – | – | ﹤0.01% | 1631 |
|
|
2022
Q3 | $42.9K | Hold |
4,155
| – | – | ﹤0.01% | 1560 |
|
|
2022
Q2 | $41.6K | Hold |
4,155
| – | – | ﹤0.01% | 1615 |
|
|
2022
Q1 | $51.1K | Sell |
4,155
-13,623
| -77% | -$168K | ﹤0.01% | 1580 |
|
|
2021
Q4 | $308K | Hold |
17,778
| – | – | ﹤0.01% | 1725 |
|
|
2021
Q3 | $319K | Hold |
17,778
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q2 | $406K | Buy |
17,778
+1,593
| +10% | +$36.4K | 0.01% | 1654 |
|
|
2021
Q1 | $242K | Buy |
16,185
+10,523
| +186% | +$157K | ﹤0.01% | 1885 |
|
|
2020
Q4 | $30.6K | Buy |
5,662
+2,247
| +66% | +$12.1K | ﹤0.01% | 2499 |
|
|
2020
Q3 | $15.5K | Sell |
3,415
-14,370
| -81% | -$65.4K | ﹤0.01% | 2538 |
|
|
2020
Q2 | $87.5K | Buy |
+17,785
| New | +$87.5K | ﹤0.01% | 2334 |
|